Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 12, 2016 - Issue
Submit an article Journal homepage
81
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Neuroleptic malignant syndrome and subsequent clozapine-withdrawal effects in a patient with refractory schizophrenia

Minfeng ChengDepartment of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
,
Huaying GuDepartment of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
,
Liangrong ZhengDepartment of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
,
Houliang WangDepartment of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
,
Zhiyong ZhongDepartment of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of China
&
Shenglin WenDepartment of Psychiatry, Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
Pages 695-697 | Published online: 29 Mar 2016

References

  • AnanthJParameswaranSGunatilakeSBurgoyneKSidhomTNeuroleptic malignant syndrome and atypical antipsychotic drugsJ Clin Psychiatry20046546447015119907
  • GambassiGCapursoSTarsitaniPLiperotiRBernabeiRFatal neuroleptic malignant syndrome in a previously long-term user of clozapine following its reintroduction in combination with paroxetineAging Clin Exp Res20061826627016804375
  • StanillaJKde LeonJSimpsonGMClozapine withdrawal resulted in delirium with psychosis: a report of three casesJ Clin Psychiatry1997582522559228890
  • LeeJWRobertsonSClozapine withdrawal catatonia and neuroleptic malignant syndrome: a case reportAnn Clin Psychiatry199791651699339882
  • StrawnJRKeckPEJrCaroffSNNeuroleptic malignant syndromeAm J Psychiatry200716487087617541044
  • KawanishiCGenetic predisposition to neuroleptic malignant syndrome: implications for antipsychotic therapyAm J Pharmacogenomics20033899512749726
  • KhaldiSKornreichCChoubaniZGourevitchRAntipsychotiques atypiques et syndrome malin des neuroleptiques: brève revue de la littérature [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review]Encephale200834618624 French19081460
  • QureshiNAAl-HabeebTASympathoadrenal hyperactivity and neuroleptic malignant syndromeAm J Psychiatry200015731031110671434
  • GabelliniASPezzoliADe MassisPCasadeiGGrilloASacquegnaTNeuroleptic malignant syndrome in an AIDS patient: clinical and pathological findingsItal J Neurol Sci1994152932957843944
  • LevittAJMidhaRCravenJLNeuroleptic malignant syndrome with intravenous haloperidolCan J Psychiatry1990357892282634
  • RosebushPIStewartTMazurekMFThe treatment of neuroleptic malignant syndrome: are dantrolene and bromocriptine useful adjuncts to supportive care?Br J Psychiatry19911597097121843801
  • ReillyJJCroweSFLloydJHNeuroleptic toxicity syndromes: a clinical spectrumAust N Z J Psychiatry1991254995051686547
  • VergheseCDeLeonJNairCSimpsonGMClozapine withdrawal effects and receptor profiles of typical and atypical neurolepticsBiol Psychiatry1996391351388717612

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.